Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn

Table of Contents

March 01, 1997; Volume 25,Issue 3

Articles

  • You have access
    Characterization of the Metabolites of Carbamazepine in Patient Urine by Liquid Chromatography/Mass Spectrometry
    J. L. Maggs, M. Pirmohamed, N. R. Kitteringham and B. K. Park
    Drug Metabolism and Disposition March 1997, 25 (3) 275-280;
  • You have access
    Enantioselective Local Disposition of Semotiadil (R-Enantiomer) and Levosemotiadil (S-Enantiomer) in Perfused Rat Liver
    Kenji Ueda, Kiyoshi Yamaoka, Maria Esther Rodriguez, Akimasa Shibukawa and Terumichi Nakagawa
    Drug Metabolism and Disposition March 1997, 25 (3) 281-286;
  • You have access
    Inhibition of Metoprolol Metabolism by Amino Acids in Perfused Rat Livers
    Bo Wang and Hugh A. Semple
    Drug Metabolism and Disposition March 1997, 25 (3) 287-295;
  • You have access
    Effect of Phenobarbital on the Pharmacokinetics of Lidocaine, Monoethylglycinexylidide and 3-Hydroxylidocaine in the Rat: Correlation with P450 Isoform Levels
    Tatsuo Nakamoto, Yutaka Oda, Susumu Imaoka, Yoshihiko Funae and Mitsugu Fujimori
    Drug Metabolism and Disposition March 1997, 25 (3) 296-300;
  • You have access
    Microbial Models of Mammalian Metabolism
    Cecile Moussa, Patrick Houziaux, Bernard Danree and Robert Azerad
    Drug Metabolism and Disposition March 1997, 25 (3) 301-310;
  • You have access
    Microbial Models of Mammalian Metabolism
    Cecile Moussa, Patrick Houziaux, Bernard Danree and Robert Azerad
    Drug Metabolism and Disposition March 1997, 25 (3) 311-316;
  • You have access
    Residue Study of Mebendazole and Its Metabolites Hydroxy-Mebendazole and Amino-Mebendazole in Eel (Anguilla anguilla) after Bath Treatment
    E. G. Iosifidou, N. Haagsma, M. Olling, J. H. Boon and M. W. T. Tanck
    Drug Metabolism and Disposition March 1997, 25 (3) 317-320;
  • You have access
    Metabolism of Cerivastatin by Human Liver Microsomes In Vitro
    Michael Boberg, Rolf Angerbauer, Peter Fey, Wolfgang K. Kanhai, Wolfgang Karl, Armin Kern, Jürgen Ploschke and Martin Radtke
    Drug Metabolism and Disposition March 1997, 25 (3) 321-331;
  • You have access
    Metabolism and Pharmacokinetics of 1-(2′-Trimethylacetoxyethyl)-2-ethyl-3-hydroxypyridin-4-one (CP117) in the rat
    Ruksana Choudhury, Rafiu O. Epemolu, Bijaya L. Rai, Robert C. Hider and Surinder Singh
    Drug Metabolism and Disposition March 1997, 25 (3) 332-339;
  • You have access
    Biphasic Kinetics of Quaternary Ammonium Glucuronide Formation from Amitriptyline and Diphenhydramine in Human Liver Microsomes
    Ursula Breyer-Pfaff, Dorothee Fischer and Dietrich Winne
    Drug Metabolism and Disposition March 1997, 25 (3) 340-345;
  • You have access
    Dietary Modulation of Phase 1 and Phase 2 Activities with Benzo(a)pyrene and Related Compounds in the Intestine But Not the Liver of the Channel Catfish, Ictalurus punctatus
    Margaret O. James, Allen H. Altman, Karen Morris, Kevin M. Kleinow and Zeen Tong
    Drug Metabolism and Disposition March 1997, 25 (3) 346-354;
  • You have access
    Disposition of l-738,167, A Potent and Long-Acting Fibrinogen Receptor Antagonist, in Dogs
    Thomayant Prueksaritanont, Lynn M. Gorham, Jeanne A. Naue, Terrence G. Hamill, Ben C. Askew and Kamlesh P. Vyas
    Drug Metabolism and Disposition March 1997, 25 (3) 355-361;
  • You have access
    Pharmacokinetics and Metabolism of Selected Prodrugs of PMEA in Rats
    Jeng-Pyng Shaw, Michael S. Louie, V. V. Krishnamurthy, Murty N. Arimilli, Robert J. Jones, Alison M. Bidgood, William A. Lee and Kenneth C. Cundy
    Drug Metabolism and Disposition March 1997, 25 (3) 362-366;
  • You have access
    Human Colorectal Carcinoma Cells In Vitro as a Means to Assess the Metabolism of Analogs of Mycophenolic Acid
    Trevor J. Franklin, Vivien N. Jacobs, Geraint Jones and Patrick Plé
    Drug Metabolism and Disposition March 1997, 25 (3) 367-370;
  • You have access
    Absorption, Disposition Kinetics, and Metabolic Pathways of Cyclohexene Oxide in the Male Fischer 344 Rat and Female B6C3F1 Mouse
    John-Michael Sauer, Jingqi Bao, Richard L. Smith, Thomas D. McClure, Michael Mayersohn, Usha Pillai, Michael L. Cunningham and I. Glenn Sipes
    Drug Metabolism and Disposition March 1997, 25 (3) 371-378;
  • You have access
    Pharmacokinetics of SNX-111, A Selective N-Type Calcium Channel Blocker, in Rats and Cynomolgus Monkeys
    Scott Bowersox, Jaap Mandema, Katalin Tarczy-Hornoch, George Miljanich and Robert R. Luther
    Drug Metabolism and Disposition March 1997, 25 (3) 379-383;
  • You have access
    Mechanism-Based Inactivation of Mouse Hepatic Cytochrome P4502B Enzymes by Amine Metabolites of Musk Xylene
    Lois D. Lehman-McKeeman, David R. Johnson, Douglas Caudill and Sharon B. Stuard
    Drug Metabolism and Disposition March 1997, 25 (3) 384-389;

Short Communication

  • You have access
    Orphenadrine and Methimazole Inhibit Multiple Cytochrome P450 Enzymes in Human Liver Microsomes
    Zuyu Guo, Shamsi Raeissi, Rebecca B. White and Jeffrey C. Stevens
    Drug Metabolism and Disposition March 1997, 25 (3) 390-393;
Back to top
PreviousNext

In this issue

Drug Metabolism and Disposition
Vol. 25, Issue 3
1 Mar 1997
  • Table of Contents
  • Index by author
Sign up for alerts

Jump to

  • Articles
  • Short Communication
  • Most Read
Loading
  • Pharmacokinetics and Disposition of Biologics
  • Physiology of the Neonatal Gastrointestinal System
  • Tissue Drug Concentrations: Beyond the Free Drug Hypothesis
  • Metabolism and Disposition of Volanesorsen across Species
  • Transporter-Mediated Drug-Drug Interactions for E7766
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics